Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.77131131 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.77131131 |
3 | negative regulation of cell killing (GO:0031342) | 4.51298265 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.51298265 |
5 | response to peptidoglycan (GO:0032494) | 4.29247212 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.21861791 |
7 | detection of other organism (GO:0098543) | 4.01066276 |
8 | macrophage activation involved in immune response (GO:0002281) | 3.99040092 |
9 | detection of bacterium (GO:0016045) | 3.96915873 |
10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.94870559 |
11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.83511629 |
12 | neutrophil activation involved in immune response (GO:0002283) | 3.78832051 |
13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.56069707 |
14 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.43353843 |
15 | detection of external biotic stimulus (GO:0098581) | 3.41677661 |
16 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.25318183 |
17 | leukocyte aggregation (GO:0070486) | 3.24262544 |
18 | germinal center formation (GO:0002467) | 3.17905194 |
19 | regulation of mast cell degranulation (GO:0043304) | 3.16913781 |
20 | low-density lipoprotein particle clearance (GO:0034383) | 3.13754320 |
21 | response to host immune response (GO:0052572) | 3.12903085 |
22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.12903085 |
23 | positive regulation of histone deacetylation (GO:0031065) | 3.10310929 |
24 | regulation of leukocyte degranulation (GO:0043300) | 3.09118991 |
25 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.08933266 |
26 | regulation of cholesterol storage (GO:0010885) | 3.07445575 |
27 | detection of molecule of bacterial origin (GO:0032490) | 3.05419693 |
28 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.05204933 |
29 | regulation of cholesterol homeostasis (GO:2000188) | 3.04786567 |
30 | response to laminar fluid shear stress (GO:0034616) | 3.04042128 |
31 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00495931 |
32 | response to host (GO:0075136) | 3.00495931 |
33 | response to host defenses (GO:0052200) | 3.00495931 |
34 | detection of biotic stimulus (GO:0009595) | 2.99528142 |
35 | positive thymic T cell selection (GO:0045059) | 2.98776700 |
36 | response to type I interferon (GO:0034340) | 2.95112784 |
37 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94010885 |
38 | type I interferon signaling pathway (GO:0060337) | 2.93277496 |
39 | cellular response to type I interferon (GO:0071357) | 2.93277496 |
40 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.92994742 |
41 | morphogenesis of an endothelium (GO:0003159) | 2.92423331 |
42 | endothelial tube morphogenesis (GO:0061154) | 2.92423331 |
43 | positive regulation of B cell differentiation (GO:0045579) | 2.91762814 |
44 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.90103956 |
45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90069075 |
46 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.88560577 |
47 | respiratory burst (GO:0045730) | 2.83929167 |
48 | neutrophil activation (GO:0042119) | 2.82407037 |
49 | growth hormone receptor signaling pathway (GO:0060396) | 2.80492540 |
50 | macrophage activation (GO:0042116) | 2.80299725 |
51 | valine metabolic process (GO:0006573) | 2.79359307 |
52 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.78316413 |
53 | pentose-phosphate shunt (GO:0006098) | 2.78313707 |
54 | granulocyte activation (GO:0036230) | 2.78193830 |
55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.77806549 |
56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.77399640 |
57 | positive regulation by symbiont of host defense response (GO:0052509) | 2.74842378 |
58 | modulation by symbiont of host defense response (GO:0052031) | 2.74842378 |
59 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.74842378 |
60 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.74842378 |
61 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.74842378 |
62 | modulation by symbiont of host immune response (GO:0052553) | 2.74842378 |
63 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73558775 |
64 | negative regulation of innate immune response (GO:0045824) | 2.73330034 |
65 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.72472298 |
66 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.71413186 |
67 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70418579 |
68 | myeloid cell activation involved in immune response (GO:0002275) | 2.69539630 |
69 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.68498854 |
70 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.67616723 |
71 | modulation by symbiont of host cellular process (GO:0044068) | 2.67595973 |
72 | defense response to protozoan (GO:0042832) | 2.67193983 |
73 | alpha-linolenic acid metabolic process (GO:0036109) | 2.66927875 |
74 | regulation of antigen processing and presentation (GO:0002577) | 2.63308541 |
75 | positive regulation of antigen processing and presentation (GO:0002579) | 2.60783107 |
76 | negative regulation of cholesterol transport (GO:0032375) | 2.60518510 |
77 | negative regulation of sterol transport (GO:0032372) | 2.60518510 |
78 | apoptotic cell clearance (GO:0043277) | 2.59854346 |
79 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59249328 |
80 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.58801446 |
81 | protein carboxylation (GO:0018214) | 2.58801446 |
82 | plasma lipoprotein particle clearance (GO:0034381) | 2.58236736 |
83 | negative regulation of granulocyte differentiation (GO:0030853) | 2.58140808 |
84 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.55805793 |
85 | response to protozoan (GO:0001562) | 2.54307359 |
86 | modulation by virus of host process (GO:0019054) | 2.53308876 |
87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.52947271 |
88 | complement activation, alternative pathway (GO:0006957) | 2.50532143 |
89 | endothelial cell chemotaxis (GO:0035767) | 2.50275966 |
90 | regulation of regulated secretory pathway (GO:1903305) | 2.50115547 |
91 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.49956290 |
92 | regulation of T cell tolerance induction (GO:0002664) | 2.49903645 |
93 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.49197997 |
94 | protein-lipid complex assembly (GO:0065005) | 2.48633458 |
95 | T cell selection (GO:0045058) | 2.48160875 |
96 | lysine catabolic process (GO:0006554) | 2.47946886 |
97 | lysine metabolic process (GO:0006553) | 2.47946886 |
98 | myeloid dendritic cell differentiation (GO:0043011) | 2.47811431 |
99 | B cell receptor signaling pathway (GO:0050853) | 2.47336341 |
100 | negative regulation of interleukin-6 production (GO:0032715) | 2.45595187 |
101 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.45252003 |
102 | L-phenylalanine metabolic process (GO:0006558) | 2.45050351 |
103 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.45050351 |
104 | maternal placenta development (GO:0001893) | 2.44054946 |
105 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.43842846 |
106 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.43389384 |
107 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.43019875 |
108 | NADPH regeneration (GO:0006740) | 2.42448697 |
109 | mannose metabolic process (GO:0006013) | 2.42269495 |
110 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.42252799 |
111 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.41423719 |
112 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.41419015 |
113 | regulation of triglyceride catabolic process (GO:0010896) | 2.40942096 |
114 | regulation of necrotic cell death (GO:0010939) | 2.40737114 |
115 | protein localization to endosome (GO:0036010) | 2.40732095 |
116 | cellular response to growth hormone stimulus (GO:0071378) | 2.39958985 |
117 | positive regulation of protein deacetylation (GO:0090312) | 2.39074945 |
118 | response to muramyl dipeptide (GO:0032495) | 2.38835766 |
119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.37678844 |
120 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.37468048 |
121 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.37468048 |
122 | negative regulation of interleukin-12 production (GO:0032695) | 2.36440812 |
123 | cellular extravasation (GO:0045123) | 2.35894712 |
124 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.35033885 |
125 | regulation of necroptotic process (GO:0060544) | 2.35022292 |
126 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.34780427 |
127 | urea cycle (GO:0000050) | 2.34655794 |
128 | urea metabolic process (GO:0019627) | 2.34655794 |
129 | phospholipid efflux (GO:0033700) | 2.34492587 |
130 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.34197838 |
131 | B cell mediated immunity (GO:0019724) | 2.33968870 |
132 | microglial cell activation (GO:0001774) | 2.33910244 |
133 | NIK/NF-kappaB signaling (GO:0038061) | 2.33313033 |
134 | immunoglobulin mediated immune response (GO:0016064) | 2.33034544 |
135 | T-helper 1 type immune response (GO:0042088) | 2.32546777 |
136 | positive regulation of lipid storage (GO:0010884) | 2.32352392 |
137 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.31937097 |
138 | plasma lipoprotein particle assembly (GO:0034377) | 2.31867387 |
139 | myeloid dendritic cell activation (GO:0001773) | 2.31709616 |
140 | 2-oxoglutarate metabolic process (GO:0006103) | 2.31702366 |
141 | natural killer cell differentiation (GO:0001779) | 2.30647756 |
142 | positive regulation of p38MAPK cascade (GO:1900745) | 2.30546466 |
143 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.30331523 |
144 | thymic T cell selection (GO:0045061) | 2.29560530 |
145 | angiogenesis involved in wound healing (GO:0060055) | 2.29368448 |
146 | positive regulation of interferon-alpha production (GO:0032727) | 2.28900626 |
147 | tricarboxylic acid metabolic process (GO:0072350) | 2.28005833 |
148 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.27577710 |
149 | pinocytosis (GO:0006907) | 2.27397885 |
150 | cysteine metabolic process (GO:0006534) | 2.26637806 |
151 | L-phenylalanine catabolic process (GO:0006559) | 2.25573723 |
152 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.25573723 |
153 | regulation of B cell differentiation (GO:0045577) | 2.24980464 |
154 | regulation of superoxide anion generation (GO:0032928) | 2.24439759 |
155 | negative regulation of fibrinolysis (GO:0051918) | 2.22630734 |
156 | positive regulation of lamellipodium assembly (GO:0010592) | 2.21154662 |
157 | apoptotic process involved in morphogenesis (GO:0060561) | 2.18438297 |
158 | sulfur amino acid catabolic process (GO:0000098) | 2.17029651 |
159 | phospholipid homeostasis (GO:0055091) | 2.16857657 |
160 | defense response to fungus (GO:0050832) | 2.15687879 |
161 | tolerance induction (GO:0002507) | 2.15298924 |
162 | regulation of interferon-alpha production (GO:0032647) | 2.14493208 |
163 | glyoxylate metabolic process (GO:0046487) | 2.14280510 |
164 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.11907932 |
165 | ethanol oxidation (GO:0006069) | 2.11745348 |
166 | negative regulation of phagocytosis (GO:0050765) | 2.11487844 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.59460241 |
2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.94061589 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.83756071 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 2.83579915 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.66563874 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.63430842 |
7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.61435933 |
8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60476686 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34705204 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.24494957 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20059356 |
12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13843000 |
13 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13403046 |
14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.11440998 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.07257503 |
16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07243625 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06854333 |
18 | * MAF_26560356_Chip-Seq_TH1_Human | 2.01929387 |
19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.01380310 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87370831 |
21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84802402 |
22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84719987 |
23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84022817 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83119392 |
25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82799833 |
26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.79970485 |
27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76058231 |
28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.75862772 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75699370 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73443005 |
31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73261480 |
32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70600884 |
33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.66571183 |
34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65987035 |
35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65502170 |
36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65169355 |
37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64746965 |
38 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.64611796 |
39 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.63427297 |
40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.62473257 |
41 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61790389 |
42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52923032 |
43 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50701238 |
44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.49799336 |
45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49796418 |
46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48568035 |
47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48457886 |
48 | MYB_26560356_Chip-Seq_TH1_Human | 1.46711503 |
49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46455511 |
50 | MYB_26560356_Chip-Seq_TH2_Human | 1.44893009 |
51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43047167 |
52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42954895 |
53 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40214484 |
54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39871287 |
55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39546396 |
56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39312140 |
57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39286472 |
58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39119188 |
59 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38516098 |
60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36754386 |
61 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.36166008 |
62 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.33350973 |
63 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33291716 |
64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32945699 |
65 | * MAF_26560356_Chip-Seq_TH2_Human | 1.32943034 |
66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32710926 |
67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32654102 |
68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32211105 |
69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31145631 |
70 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30403118 |
71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30353589 |
72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29909588 |
73 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.29833516 |
74 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28862644 |
75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28564474 |
76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26869104 |
77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25187005 |
78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24529444 |
79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23821486 |
80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22359361 |
81 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21556600 |
82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19754216 |
83 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19452641 |
84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19359443 |
85 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.19291379 |
86 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18896804 |
87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18278246 |
88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17478932 |
89 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17355750 |
90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16818957 |
91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16670079 |
92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15734665 |
93 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15644929 |
94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14586193 |
95 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13044246 |
96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11710655 |
97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10291294 |
98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10274245 |
99 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.09859983 |
100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08566584 |
101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07964292 |
102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07686316 |
103 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06752025 |
104 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05950818 |
105 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05523340 |
106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.05505821 |
107 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05132885 |
108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04986618 |
109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04601462 |
110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04117254 |
111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03601201 |
112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03544382 |
113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02547824 |
114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02469381 |
115 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01634157 |
116 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01438689 |
117 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00785805 |
118 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00596862 |
119 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99000931 |
120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98997367 |
121 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98386118 |
122 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98258912 |
123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97394490 |
124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97307362 |
125 | * P68_20966046_ChIP-Seq_HELA_Human | 0.97237910 |
126 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96907880 |
127 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94981191 |
128 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93682124 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009840_abnormal_foam_cell | 3.01075441 |
2 | MP0005360_urolithiasis | 2.82723731 |
3 | MP0003300_gastrointestinal_ulcer | 2.71986516 |
4 | MP0003705_abnormal_hypodermis_morpholog | 2.67869846 |
5 | MP0003172_abnormal_lysosome_physiology | 2.50419275 |
6 | MP0003303_peritoneal_inflammation | 2.44676853 |
7 | MP0003191_abnormal_cellular_cholesterol | 2.44545110 |
8 | MP0002139_abnormal_hepatobiliary_system | 2.31812922 |
9 | MP0010368_abnormal_lymphatic_system | 2.28012691 |
10 | MP0000685_abnormal_immune_system | 2.17413507 |
11 | MP0003436_decreased_susceptibility_to | 2.14101806 |
12 | MP0008260_abnormal_autophagy | 2.08628905 |
13 | MP0009278_abnormal_bone_marrow | 1.95841787 |
14 | MP0001835_abnormal_antigen_presentation | 1.84680967 |
15 | MP0005365_abnormal_bile_salt | 1.80851794 |
16 | MP0002138_abnormal_hepatobiliary_system | 1.79389353 |
17 | MP0005387_immune_system_phenotype | 1.74788302 |
18 | MP0001790_abnormal_immune_system | 1.74788302 |
19 | MP0005464_abnormal_platelet_physiology | 1.67533297 |
20 | MP0010352_gastrointestinal_tract_polyps | 1.67106608 |
21 | MP0001800_abnormal_humoral_immune | 1.64940039 |
22 | MP0004947_skin_inflammation | 1.64099346 |
23 | MP0005058_abnormal_lysosome_morphology | 1.60773862 |
24 | MP0005085_abnormal_gallbladder_physiolo | 1.59746682 |
25 | MP0005025_abnormal_response_to | 1.57768264 |
26 | MP0005083_abnormal_biliary_tract | 1.56727907 |
27 | MP0004381_abnormal_hair_follicle | 1.56275489 |
28 | MP0003566_abnormal_cell_adhesion | 1.54320538 |
29 | MP0003183_abnormal_peptide_metabolism | 1.53350676 |
30 | MP0004510_myositis | 1.53040189 |
31 | MP0010155_abnormal_intestine_physiology | 1.51025519 |
32 | MP0002452_abnormal_antigen_presenting | 1.48941921 |
33 | MP0002419_abnormal_innate_immunity | 1.47458418 |
34 | MP0002166_altered_tumor_susceptibility | 1.46355019 |
35 | MP0000858_altered_metastatic_potential | 1.45465008 |
36 | MP0003075_altered_response_to | 1.44926524 |
37 | MP0005397_hematopoietic_system_phenotyp | 1.44414091 |
38 | MP0001545_abnormal_hematopoietic_system | 1.44414091 |
39 | MP0009785_altered_susceptibility_to | 1.43711735 |
40 | MP0005000_abnormal_immune_tolerance | 1.43210964 |
41 | MP0000465_gastrointestinal_hemorrhage | 1.43145116 |
42 | MP0003724_increased_susceptibility_to | 1.43127249 |
43 | MP0002998_abnormal_bone_remodeling | 1.41757735 |
44 | MP0002723_abnormal_immune_serum | 1.40598565 |
45 | MP0010329_abnormal_lipoprotein_level | 1.40426609 |
46 | MP0002396_abnormal_hematopoietic_system | 1.40020350 |
47 | MP0000609_abnormal_liver_physiology | 1.39524521 |
48 | MP0005310_abnormal_salivary_gland | 1.38781538 |
49 | MP0003252_abnormal_bile_duct | 1.38463002 |
50 | MP0001873_stomach_inflammation | 1.37582389 |
51 | MP0001879_abnormal_lymphatic_vessel | 1.36629329 |
52 | MP0002405_respiratory_system_inflammati | 1.36181486 |
53 | MP0003763_abnormal_thymus_physiology | 1.35541038 |
54 | MP0002420_abnormal_adaptive_immunity | 1.34460579 |
55 | MP0001819_abnormal_immune_cell | 1.33462586 |
56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.33081719 |
57 | MP0005167_abnormal_blood-brain_barrier | 1.30685016 |
58 | MP0004858_abnormal_nervous_system | 1.30304600 |
59 | MP0009333_abnormal_splenocyte_physiolog | 1.27869701 |
60 | MP0006082_CNS_inflammation | 1.27526702 |
61 | MP0002398_abnormal_bone_marrow | 1.27494294 |
62 | MP0004808_abnormal_hematopoietic_stem | 1.23896842 |
63 | MP0001845_abnormal_inflammatory_respons | 1.22447693 |
64 | MP0001666_abnormal_nutrient_absorption | 1.21771571 |
65 | MP0000689_abnormal_spleen_morphology | 1.21204014 |
66 | MP0000716_abnormal_immune_system | 1.19445309 |
67 | MP0005671_abnormal_response_to | 1.18458597 |
68 | MP0002722_abnormal_immune_system | 1.16685805 |
69 | MP0008469_abnormal_protein_level | 1.14391408 |
70 | MP0009764_decreased_sensitivity_to | 1.13314489 |
71 | MP0003866_abnormal_defecation | 1.13182529 |
72 | MP0005023_abnormal_wound_healing | 1.11649478 |
73 | MP0002429_abnormal_blood_cell | 1.10430529 |
74 | MP0000604_amyloidosis | 1.09476009 |
75 | MP0004185_abnormal_adipocyte_glucose | 1.09294406 |
76 | MP0009643_abnormal_urine_homeostasis | 1.09192207 |
77 | MP0002254_reproductive_system_inflammat | 1.07027543 |
78 | MP0001533_abnormal_skeleton_physiology | 1.06104907 |
79 | MP0001853_heart_inflammation | 1.05177504 |
80 | MP0005076_abnormal_cell_differentiation | 1.04116791 |
81 | MP0003453_abnormal_keratinocyte_physiol | 1.03624787 |
82 | MP0005166_decreased_susceptibility_to | 1.03201750 |
83 | MP0005409_darkened_coat_color | 1.03114506 |
84 | MP0006054_spinal_hemorrhage | 1.02825751 |
85 | MP0003091_abnormal_cell_migration | 1.02762363 |
86 | MP0000598_abnormal_liver_morphology | 1.02481578 |
87 | MP0001663_abnormal_digestive_system | 1.00675346 |
88 | MP0002132_abnormal_respiratory_system | 0.98499435 |
89 | MP0005451_abnormal_body_composition | 0.97903008 |
90 | MP0002148_abnormal_hypersensitivity_rea | 0.97346809 |
91 | MP0003828_pulmonary_edema | 0.96850295 |
92 | MP0005319_abnormal_enzyme/_coenzyme | 0.95981156 |
93 | MP0008961_abnormal_basal_metabolism | 0.92398428 |
94 | MP0002933_joint_inflammation | 0.91108477 |
95 | MP0002877_abnormal_melanocyte_morpholog | 0.90488275 |
96 | MP0005390_skeleton_phenotype | 0.90386050 |
97 | MP0001851_eye_inflammation | 0.90009067 |
98 | MP0003656_abnormal_erythrocyte_physiolo | 0.89965496 |
99 | MP0000249_abnormal_blood_vessel | 0.88366181 |
100 | MP0010234_abnormal_vibrissa_follicle | 0.87751211 |
101 | MP0005666_abnormal_adipose_tissue | 0.87710299 |
102 | MP0002136_abnormal_kidney_physiology | 0.87462074 |
103 | MP0002006_tumorigenesis | 0.87355808 |
104 | MP0003690_abnormal_glial_cell | 0.85960868 |
105 | MP0003806_abnormal_nucleotide_metabolis | 0.85664083 |
106 | MP0000703_abnormal_thymus_morphology | 0.85214866 |
107 | MP0000490_abnormal_crypts_of | 0.85078896 |
108 | MP0001849_ear_inflammation | 0.84412328 |
109 | MP0000767_abnormal_smooth_muscle | 0.84359247 |
110 | MP0005670_abnormal_white_adipose | 0.84143283 |
111 | MP0000343_altered_response_to | 0.84025637 |
112 | MP0001915_intracranial_hemorrhage | 0.84013125 |
113 | MP0002118_abnormal_lipid_homeostasis | 0.83051527 |
114 | MP0009763_increased_sensitivity_to | 0.82492025 |
115 | MP0004264_abnormal_extraembryonic_tissu | 0.82371285 |
116 | MP0010630_abnormal_cardiac_muscle | 0.82159120 |
117 | MP0004272_abnormal_basement_membrane | 0.80947668 |
118 | MP0003279_aneurysm | 0.80671064 |
119 | MP0003329_amyloid_beta_deposits | 0.80303874 |
120 | MP0010307_abnormal_tumor_latency | 0.80060993 |
121 | MP0003448_altered_tumor_morphology | 0.79850720 |
122 | MP0005332_abnormal_amino_acid | 0.78625617 |
123 | MP0004883_abnormal_blood_vessel | 0.77778281 |
124 | MP0005164_abnormal_response_to | 0.77007148 |
125 | MP0000678_abnormal_parathyroid_gland | 0.73297013 |
126 | MP0005375_adipose_tissue_phenotype | 0.71006022 |
127 | MP0005075_abnormal_melanosome_morpholog | 0.70394315 |
128 | MP0000015_abnormal_ear_pigmentation | 0.69135172 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Spontaneous hematomas (HP:0007420) | 3.65476986 |
2 | Orchitis (HP:0100796) | 3.62379995 |
3 | Deep venous thrombosis (HP:0002625) | 3.57181560 |
4 | Eczematoid dermatitis (HP:0000976) | 3.43396269 |
5 | Polycythemia (HP:0001901) | 3.40821972 |
6 | Systemic lupus erythematosus (HP:0002725) | 3.36649931 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.30667276 |
8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.30667276 |
9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.30667276 |
10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.22286555 |
11 | Obstructive lung disease (HP:0006536) | 3.22286555 |
12 | Abnormality of the nasal mucosa (HP:0000433) | 3.18814448 |
13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.17537877 |
14 | Hematochezia (HP:0002573) | 3.15688826 |
15 | Mediastinal lymphadenopathy (HP:0100721) | 3.09934864 |
16 | Retrobulbar optic neuritis (HP:0100654) | 3.06963863 |
17 | Optic neuritis (HP:0100653) | 3.06963863 |
18 | Esophageal varix (HP:0002040) | 3.03791961 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 2.91581563 |
20 | Xanthomatosis (HP:0000991) | 2.89685433 |
21 | Gingivitis (HP:0000230) | 2.89459171 |
22 | Complement deficiency (HP:0004431) | 2.88180226 |
23 | Meningitis (HP:0001287) | 2.80006450 |
24 | Pustule (HP:0200039) | 2.79973844 |
25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78572219 |
26 | Cerebral aneurysm (HP:0004944) | 2.73418736 |
27 | Myocardial infarction (HP:0001658) | 2.72375082 |
28 | Gastrointestinal infarctions (HP:0005244) | 2.69462204 |
29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66110225 |
30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.65437789 |
31 | Stomatitis (HP:0010280) | 2.62388581 |
32 | Purpura (HP:0000979) | 2.58605597 |
33 | Nasal polyposis (HP:0100582) | 2.57071633 |
34 | Abnormality of complement system (HP:0005339) | 2.56333920 |
35 | Cellulitis (HP:0100658) | 2.56163121 |
36 | Interstitial pulmonary disease (HP:0006530) | 2.54318043 |
37 | Amyloidosis (HP:0011034) | 2.53146535 |
38 | Recurrent fungal infections (HP:0002841) | 2.47163553 |
39 | Vasculitis (HP:0002633) | 2.46882807 |
40 | Chronic otitis media (HP:0000389) | 2.46500863 |
41 | Recurrent abscess formation (HP:0002722) | 2.45609068 |
42 | Gastrointestinal inflammation (HP:0004386) | 2.43386124 |
43 | Abnormal platelet function (HP:0011869) | 2.43316901 |
44 | Impaired platelet aggregation (HP:0003540) | 2.43316901 |
45 | Colitis (HP:0002583) | 2.43069713 |
46 | Glomerulonephritis (HP:0000099) | 2.41654767 |
47 | Recurrent viral infections (HP:0004429) | 2.41317466 |
48 | Inflammation of the large intestine (HP:0002037) | 2.38014526 |
49 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.37627276 |
50 | Vacuolated lymphocytes (HP:0001922) | 2.34026098 |
51 | Recurrent bacterial skin infections (HP:0005406) | 2.33356465 |
52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.28752189 |
53 | Malnutrition (HP:0004395) | 2.28685965 |
54 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.24459521 |
55 | Abnormality of macrophages (HP:0004311) | 2.23428523 |
56 | Polygenic inheritance (HP:0010982) | 2.21204123 |
57 | Axonal loss (HP:0003447) | 2.20421113 |
58 | Hemoptysis (HP:0002105) | 2.20129518 |
59 | Epistaxis (HP:0000421) | 2.19394908 |
60 | IgM deficiency (HP:0002850) | 2.18770184 |
61 | Encephalitis (HP:0002383) | 2.17987352 |
62 | Keratoconjunctivitis sicca (HP:0001097) | 2.17431496 |
63 | Intrahepatic cholestasis (HP:0001406) | 2.17317215 |
64 | Increased IgE level (HP:0003212) | 2.16530569 |
65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.14865164 |
66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.14865164 |
67 | Asymmetric septal hypertrophy (HP:0001670) | 2.14118012 |
68 | Fatigue (HP:0012378) | 2.13849289 |
69 | Joint hemorrhage (HP:0005261) | 2.13787177 |
70 | Pulmonary infiltrates (HP:0002113) | 2.12833520 |
71 | Dysostosis multiplex (HP:0000943) | 2.12570552 |
72 | Chest pain (HP:0100749) | 2.11457210 |
73 | Abnormality of the common coagulation pathway (HP:0010990) | 2.11005358 |
74 | Hypochromic anemia (HP:0001931) | 2.10359295 |
75 | Broad face (HP:0000283) | 2.09554879 |
76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07552824 |
77 | Peritonitis (HP:0002586) | 2.06962683 |
78 | Hypertriglyceridemia (HP:0002155) | 2.06299814 |
79 | Gingival bleeding (HP:0000225) | 2.05981631 |
80 | Increased serum ferritin (HP:0003281) | 2.04275059 |
81 | J-shaped sella turcica (HP:0002680) | 2.03810188 |
82 | Hemorrhage of the eye (HP:0011885) | 2.02088560 |
83 | Verrucae (HP:0200043) | 2.01974051 |
84 | Papilloma (HP:0012740) | 2.01974051 |
85 | Myositis (HP:0100614) | 2.01170438 |
86 | Thrombocytosis (HP:0001894) | 2.00750330 |
87 | Prolonged bleeding time (HP:0003010) | 2.00173553 |
88 | Arterial thrombosis (HP:0004420) | 1.99466233 |
89 | Nephritis (HP:0000123) | 1.99428362 |
90 | Recurrent skin infections (HP:0001581) | 1.97467140 |
91 | Gastrointestinal stroma tumor (HP:0100723) | 1.97337993 |
92 | Thoracic kyphosis (HP:0002942) | 1.96168808 |
93 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.95477751 |
94 | Loss of speech (HP:0002371) | 1.95433180 |
95 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94089872 |
96 | Mucopolysacchariduria (HP:0008155) | 1.94089872 |
97 | Vertebral compression fractures (HP:0002953) | 1.94023934 |
98 | Recurrent bronchitis (HP:0002837) | 1.93905759 |
99 | Keratoconjunctivitis (HP:0001096) | 1.93374741 |
100 | Hyperlipoproteinemia (HP:0010980) | 1.92743018 |
101 | Hepatosplenomegaly (HP:0001433) | 1.92739264 |
102 | Hypertensive crisis (HP:0100735) | 1.92597480 |
103 | Abnormality of the fingertips (HP:0001211) | 1.92538487 |
104 | Pulmonary embolism (HP:0002204) | 1.91941211 |
105 | Osteomyelitis (HP:0002754) | 1.90706249 |
106 | Increased connective tissue (HP:0009025) | 1.88884000 |
107 | Abnormal platelet volume (HP:0011876) | 1.87891209 |
108 | Pathologic fracture (HP:0002756) | 1.87093909 |
109 | Hypercholesterolemia (HP:0003124) | 1.87080405 |
110 | Abnormality of iron homeostasis (HP:0011031) | 1.86857323 |
111 | Flat acetabular roof (HP:0003180) | 1.86229682 |
112 | Reticulocytosis (HP:0001923) | 1.85304131 |
113 | Lymphangioma (HP:0100764) | 1.82825342 |
114 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.82651900 |
115 | Ulnar bowing (HP:0003031) | 1.82641133 |
116 | Obstructive sleep apnea (HP:0002870) | 1.82330590 |
117 | Aneurysm (HP:0002617) | 1.82288366 |
118 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.82275211 |
119 | Menorrhagia (HP:0000132) | 1.82216798 |
120 | Restrictive lung disease (HP:0002091) | 1.82138523 |
121 | Abnormality of T cell physiology (HP:0011840) | 1.81939187 |
122 | Increased cerebral lipofuscin (HP:0011813) | 1.81838774 |
123 | Microcytic anemia (HP:0001935) | 1.81746136 |
124 | Urticaria (HP:0001025) | 1.81599704 |
125 | Periodontitis (HP:0000704) | 1.81247699 |
126 | Osteolytic defects of the hand bones (HP:0009699) | 1.81103625 |
127 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.81103625 |
128 | Distal lower limb muscle weakness (HP:0009053) | 1.80873987 |
129 | Hypoglycemic coma (HP:0001325) | 1.80826836 |
130 | Hyperammonemia (HP:0001987) | 1.80681226 |
131 | Abnormality of the thoracic spine (HP:0100711) | 1.79616608 |
132 | Acne (HP:0001061) | 1.78732096 |
133 | Disproportionate tall stature (HP:0001519) | 1.78055392 |
134 | Episodic fever (HP:0001954) | 1.77578185 |
135 | Abnormality of the peritoneum (HP:0002585) | 1.77288786 |
136 | Conjunctival telangiectasia (HP:0000524) | 1.76534462 |
137 | Mesangial abnormality (HP:0001966) | 1.76480856 |
138 | Late onset (HP:0003584) | 1.76455341 |
139 | Abnormality of T cells (HP:0002843) | 1.74707410 |
140 | Thrombophlebitis (HP:0004418) | 1.74209895 |
141 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73837187 |
142 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73837187 |
143 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73837187 |
144 | Hypergammaglobulinemia (HP:0010702) | 1.73714972 |
145 | Petechiae (HP:0000967) | 1.73568769 |
146 | Emphysema (HP:0002097) | 1.73316605 |
147 | Hyperacusis (HP:0010780) | 1.73243024 |
148 | Nonimmune hydrops fetalis (HP:0001790) | 1.72970525 |
149 | Increased density of long bones (HP:0006392) | 1.72740440 |
150 | Anorexia (HP:0002039) | 1.72640973 |
151 | Thin bony cortex (HP:0002753) | 1.72606093 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 3.82613188 |
2 | ERN1 | 3.60306546 |
3 | MAP3K10 | 3.19077155 |
4 | PKN2 | 3.06856468 |
5 | RIPK4 | 2.97023297 |
6 | PRPF4B | 2.73583711 |
7 | EEF2K | 2.63424610 |
8 | * MAP4K1 | 2.62703732 |
9 | KDR | 2.50964850 |
10 | SMG1 | 2.40400872 |
11 | EPHB1 | 2.29510820 |
12 | TGFBR2 | 2.23021819 |
13 | TIE1 | 2.22300846 |
14 | PTK6 | 1.96890422 |
15 | TNK2 | 1.95903711 |
16 | STK10 | 1.93581497 |
17 | TBK1 | 1.91959886 |
18 | MAP2K3 | 1.90388695 |
19 | TYK2 | 1.87486424 |
20 | FGFR4 | 1.84000809 |
21 | BLK | 1.83338683 |
22 | ZAP70 | 1.81681996 |
23 | LRRK2 | 1.67911435 |
24 | FES | 1.67883223 |
25 | JAK3 | 1.63690650 |
26 | TTN | 1.57874085 |
27 | PRKD2 | 1.55378662 |
28 | RIPK1 | 1.52097617 |
29 | MAP3K13 | 1.51797885 |
30 | SIK1 | 1.47147375 |
31 | GRK6 | 1.41669069 |
32 | TAOK2 | 1.37839113 |
33 | KIT | 1.32903807 |
34 | MARK2 | 1.32227517 |
35 | FLT3 | 1.29788708 |
36 | BTK | 1.29692617 |
37 | CSK | 1.22234074 |
38 | CSF1R | 1.22184589 |
39 | RPS6KA4 | 1.21272981 |
40 | FGR | 1.20801346 |
41 | TGFBR1 | 1.15279641 |
42 | MAP3K3 | 1.15110825 |
43 | CDK12 | 1.14697172 |
44 | CDC42BPA | 1.13763006 |
45 | BMX | 1.11892695 |
46 | MST1R | 1.10045371 |
47 | PAK4 | 1.08802803 |
48 | BCKDK | 1.05820486 |
49 | IKBKE | 1.05729503 |
50 | CAMK1D | 1.04926570 |
51 | PDPK1 | 1.02799434 |
52 | TAOK3 | 1.01445546 |
53 | EPHA2 | 1.00131054 |
54 | MAP2K2 | 0.98548967 |
55 | JAK1 | 0.97599536 |
56 | SIK3 | 0.95821317 |
57 | SCYL2 | 0.94869007 |
58 | TAOK1 | 0.94170263 |
59 | ITK | 0.93665020 |
60 | IRAK2 | 0.93448784 |
61 | MATK | 0.90317177 |
62 | JAK2 | 0.88571453 |
63 | HCK | 0.88565266 |
64 | ICK | 0.87867374 |
65 | MAP3K8 | 0.87849757 |
66 | * MAP3K1 | 0.85866744 |
67 | CDK4 | 0.83660116 |
68 | IKBKB | 0.80005403 |
69 | MAP3K14 | 0.78824811 |
70 | NEK2 | 0.78242417 |
71 | CDK6 | 0.77724928 |
72 | CHUK | 0.76638846 |
73 | RPS6KA2 | 0.75703966 |
74 | DMPK | 0.75348324 |
75 | PDK1 | 0.74354676 |
76 | LCK | 0.73692615 |
77 | MAP3K6 | 0.73549510 |
78 | RPS6KC1 | 0.73133953 |
79 | RPS6KL1 | 0.73133953 |
80 | PIM1 | 0.72770007 |
81 | IRAK1 | 0.72291592 |
82 | IRAK3 | 0.72205777 |
83 | MARK3 | 0.72130586 |
84 | MAP3K7 | 0.71955969 |
85 | * MAP3K11 | 0.71635330 |
86 | KSR2 | 0.70758280 |
87 | STK4 | 0.68562732 |
88 | MAPK11 | 0.67224710 |
89 | NLK | 0.65929907 |
90 | SYK | 0.65298218 |
91 | IRAK4 | 0.65110568 |
92 | MTOR | 0.64488368 |
93 | RPS6KB2 | 0.63833971 |
94 | PRKG2 | 0.63756082 |
95 | MAPK12 | 0.63272824 |
96 | PTK2 | 0.63025703 |
97 | NME2 | 0.63012169 |
98 | FGFR3 | 0.60511905 |
99 | CLK1 | 0.59350459 |
100 | MET | 0.58759787 |
101 | TESK2 | 0.58059527 |
102 | DYRK1B | 0.56795715 |
103 | CAMK1G | 0.55643814 |
104 | MAP2K6 | 0.54975412 |
105 | TEC | 0.54960015 |
106 | MAPKAPK3 | 0.53876387 |
107 | HIPK2 | 0.53503654 |
108 | MAPK15 | 0.52393738 |
109 | DDR2 | 0.51227531 |
110 | PDGFRB | 0.50530860 |
111 | MAPK7 | 0.50247046 |
112 | EPHA3 | 0.49759491 |
113 | TXK | 0.49028133 |
114 | CAMKK1 | 0.47403436 |
115 | PRKD1 | 0.46902809 |
116 | MAPKAPK2 | 0.43333599 |
117 | NEK9 | 0.43202250 |
118 | PIM2 | 0.42969558 |
119 | ILK | 0.42371396 |
120 | PTK2B | 0.41513591 |
121 | ARAF | 0.41332270 |
122 | EGFR | 0.41287926 |
123 | PRKCH | 0.41114730 |
124 | SIK2 | 0.41077289 |
125 | FYN | 0.40777779 |
126 | RPS6KA6 | 0.39984901 |
127 | PRKD3 | 0.39326848 |
128 | PAK2 | 0.38440170 |
129 | PRKAA2 | 0.38258997 |
130 | LYN | 0.37625388 |
131 | TESK1 | 0.37330685 |
132 | RET | 0.36948416 |
133 | ALK | 0.36750644 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.65246685 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.23305949 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.16136573 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.03249543 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.87585533 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.82266020 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 1.81671750 |
8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.74007786 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.71324588 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.69616377 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66341725 |
12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65387868 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61357202 |
14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60331995 |
15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59255948 |
16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.55459978 |
17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52488717 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.46954872 |
19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39317848 |
20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38978988 |
21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35487161 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34091470 |
23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30710434 |
24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.28168761 |
25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27692443 |
26 | Lysine degradation_Homo sapiens_hsa00310 | 1.27164041 |
27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.24023841 |
28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.23655953 |
29 | ABC transporters_Homo sapiens_hsa02010 | 1.17617748 |
30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17329523 |
31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17189898 |
32 | Measles_Homo sapiens_hsa05162 | 1.17128320 |
33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16954210 |
34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16016931 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.15036702 |
36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12884053 |
37 | Asthma_Homo sapiens_hsa05310 | 1.11888628 |
38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10315309 |
39 | Legionellosis_Homo sapiens_hsa05134 | 1.09449843 |
40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.09396707 |
41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09114479 |
42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.07815285 |
43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07380865 |
44 | Insulin resistance_Homo sapiens_hsa04931 | 1.06296069 |
45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06036013 |
46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03774505 |
47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01491465 |
48 | Bladder cancer_Homo sapiens_hsa05219 | 1.00190491 |
49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99793289 |
50 | Phagosome_Homo sapiens_hsa04145 | 0.99590582 |
51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97157533 |
52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96608351 |
53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96260459 |
54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96133830 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94860891 |
56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94056220 |
57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93316300 |
58 | Apoptosis_Homo sapiens_hsa04210 | 0.93010198 |
59 | Shigellosis_Homo sapiens_hsa05131 | 0.92602334 |
60 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90259900 |
61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89670646 |
62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89640741 |
63 | Bile secretion_Homo sapiens_hsa04976 | 0.89223685 |
64 | Prion diseases_Homo sapiens_hsa05020 | 0.88847633 |
65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88588811 |
66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87638292 |
67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.87050576 |
68 | Lysosome_Homo sapiens_hsa04142 | 0.86896575 |
69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86778360 |
70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86552184 |
71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84600623 |
72 | Malaria_Homo sapiens_hsa05144 | 0.84581792 |
73 | Influenza A_Homo sapiens_hsa05164 | 0.83421404 |
74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83195069 |
75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81516953 |
76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80617643 |
77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80371608 |
78 | Peroxisome_Homo sapiens_hsa04146 | 0.79443173 |
79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79387886 |
80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78974496 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78940167 |
82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78640567 |
83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78587079 |
84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78535177 |
85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78015285 |
86 | Platelet activation_Homo sapiens_hsa04611 | 0.77992377 |
87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76169026 |
88 | Hepatitis B_Homo sapiens_hsa05161 | 0.75729077 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.75469792 |
90 | Endocytosis_Homo sapiens_hsa04144 | 0.75399275 |
91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73305135 |
92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72745913 |
93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.72457959 |
94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72449047 |
95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72446954 |
96 | Tuberculosis_Homo sapiens_hsa05152 | 0.71692473 |
97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71348806 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70699493 |
99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70523184 |
100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69725080 |
101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69456599 |
102 | Hepatitis C_Homo sapiens_hsa05160 | 0.69052914 |
103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69049327 |
104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68571176 |
105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64010780 |
106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61595129 |
107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60626656 |
108 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60152120 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59780246 |
110 | Salmonella infection_Homo sapiens_hsa05132 | 0.59297050 |
111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59016600 |
112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57567889 |
113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57523299 |
114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57241720 |
115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56713215 |
116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56321258 |
117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56095888 |
118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55894089 |
119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55617850 |
120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55459232 |
121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55408737 |
122 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54262912 |
123 | Focal adhesion_Homo sapiens_hsa04510 | 0.54032550 |
124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53466570 |
125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53252068 |
126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51814885 |
127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51758851 |
128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50694326 |
129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50198212 |
130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49772302 |
131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49533503 |
132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48203258 |
133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48098937 |
134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48008734 |
135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47234236 |
136 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47200090 |
137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45312543 |
138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45288349 |